Newsfile Corp
08 Apr 2026, 14:56 UTC · 24w ago
Verdict
Headline leans bearish. We score PHR −0.90 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.90strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Phreesia, Inc. reduced its FY 2027 revenue guidance to $510-$520 million from a previous range of $545-$559 million.
More negative than 99% of claims this week
Levi & Korsinsky has commenced an investigation into Phreesia, Inc. for potential violations of federal securities laws.
Continue reading
5 related stories
More negative than 90% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 95% of claims this week
Phreesia attributed its guidance cut to weaker pharmaceutical-marketing commitments and shorter visibility in its Network Solutions segment.
More negative than 87% of claims this week
Which stocks this story touches
More negative than 90% of ticker scores this week
The company is under investigation for potential securities law violations following a significant reduction in revenue guidance and a sharp stock price drop.
More negative than 82% of ticker scores this week
The company is the subject of an investigation by a securities litigation firm regarding investor losses.
More negative than 82% of ticker scores this week
The company is being investigated by a securities litigation firm for potential securities fraud.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
+7.8%
Price is moving against the score
$9.77 vs $9.06 close before publication (Apr 7) · not market-adjusted
PHR chart →
